A-SPINE Asia Co., Ltd. (TPEX:6758)
29.45
+0.10 (0.34%)
Sep 8, 2026, 11:08 AM CST
A-SPINE Asia Market Cap
A-SPINE Asia has a market cap or net worth of 395.38 million as of September 8, 2026. Its market cap has decreased by -31.74% in one year.
Market Cap
395.38M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29.45
ChartMarket Cap Chart
Since January 2, 2020, A-SPINE Asia's market cap has decreased from 1.20B to 395.38M, a decrease of -67.02%. That is a compound annual growth rate of -15.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 395.38M | -25.70% |
| Dec 31, 2025 | 532.11M | -1.00% |
| Dec 30, 2024 | 537.49M | 2.57% |
| Dec 29, 2023 | 524.02M | 2.37% |
| Dec 30, 2022 | 511.90M | -19.23% |
| Dec 10, 2021 | 633.81M | -18.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AmCad BioMed | 915.16M |
| Cowealth Medical Holding | 910.18M |
| PlexBio | 794.99M |
| Radiant Innovation | 778.57M |
| Carilex Medical | 652.77M |
| Health & Life | 488.30M |
| Taiwan Advanced Nanotech | 348.74M |
| EPS Bio Technology | 337.96M |